Author

B. Chamberlain

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. Petrin· 1 shared A. S. Narayanan· 1 shared A. Saxton· 1 shared B. C. Johnson· 1 shared B. C. Kartchner· 1 shared B. K. Allen· 1 shared B. M. Hemeyer· 1 shared B. Tesar· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Petrin

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Design of a systemic small molecule clinical STING agonist using physics-based simulations and artificial intelligence

B. K. Allen, M. M. Kulkarni, B. Chamberlain, T. Dwight, C. Koh, R. Samant, F. Jernigan, J. Rice, D. Tan, S. Li, K. Marino, H. Huang, E. Chiswick, B. Tesar, S. Sparks, , W. Sherman

This paper designs a small molecule STING agonist, SNX281, using computational methods and AI, showing systemic activity and antitumor effects in mice.

bioRxiv · May 23, 2022 · PreprintCancer Biology

Soluble ECM promotes organotypic formation in lung alveolar model

J. C. Valdoz, N. A. Franks, C. G. Cribbs, D. J. Jacobs, E. L. Dodson, C. J. Knight, P. D. Poulson, S. R. Garfield, B. C. Johnson, B. M. Hemeyer, M. T. Sudo, J. A. Saunooke, B. C. Kartchner, A. Saxton, M. L. Vallecillo-Zuniga, , P. M. Van Ry

This study shows that adding soluble ECM to suspension culture enables the formation of organotypic lung structures from stable cell lines, including lumen-like airspaces and vasculature, and models lung fibrosis with drug testing capabilities.

bioRxiv · Sep 16, 2021Bioengineering